Wei Li
Shanghai Medical College of Fudan University(CN)Capital Medical University(CN)Jilin University(CN)Anhui Medical University(CN)Fudan University Shanghai Cancer Center(CN)Second Affiliated Hospital of Inner Mongolia Medical University(CN)Beijing Anzhen Hospital(CN)First Hospital of Jilin University(CN)First Affiliated Hospital of Anhui Medical University(CN)Shanghai Clinical Research Center(CN)
Publications by Year
Research Areas
Inflammatory Biomarkers in Disease Prognosis, Cancer, Lipids, and Metabolism, Cancer Immunotherapy and Biomarkers, Beetle Biology and Toxicology Studies, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle(2014)252 cited
- → CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer(2017)196 cited
- → Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress‐independent growth inhibition of pancreatic cancer cells through G2/M cell‐cycle arrest and apoptosis(2010)183 cited
- → The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer(2022)154 cited
- → B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer(2014)121 cited
- → Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung Cancer